Loading…
Lobbying Income
$1.3M
Filings
165
Unique Clients
8
Active Period
2017–2026
Registrant-reported income from clients on LDA filings
Largest clients by registrant-reported income
Government entities explicitly identified as targets in LDA filings
Most frequently reported lobbying issues
Bill numbers found in source-reported LDA specific issue text; broad topic matches are excluded
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel; to explore health savings accounts / flexible spending accounts in relation to dietary supplement products.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To explore the implications from mandatory dietary supplement product listing provisions (as previously included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry in the dietary supplement channel.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol ingredient; to explore the implications from mandatory dietary supplement product listing provisions (as previoulsy included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348)); to explore the role and needs of small businesses for market entry.
Client expense: — · Firm income: $10,000
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Client expense: — · Firm income: —
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Client expense: — · Firm income: —
Matched citations: S.4348
To clarify the regulatory uncertainty of the hemp-derived cannabidiol (CBD) ingredient; and to explore the implications from the mandatory dietary supplement product listing provisions as included in the Food and Drug Administration Safety and Landmark Advancements Act of 2022 (S.4348).
Client expense: — · Firm income: —
Matched citations: S.4348
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · fourth_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · fourth_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · third_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $20,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · third_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $20,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · second_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · second_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, or legislation to the effect of, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: $10,000
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances.
2020 · first_quarter · Client: TRADITIONAL MEDICINALS
To advance HR5587, which is a bill "To amend the Federal Food, Drug, and Cosmetic Act with respect to the regulation of hemp-derived cannabidiol and hemp-derived cannabidiol containing substances."
Client expense: — · Firm income: —
Matched citations: HR5587
Preserving Patient Access to Compounded Medications Act of 2017
2018 · fourth_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · fourth_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $40,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · third_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · third_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · second_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · second_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $20,000
Matched citations: H.R. 2871
Preserving Patient Access to Compounded Medications Act of 2017
2018 · first_quarter · Client: ROCK & ASSOCIATES
Legislation impacting the operation of pharmacy compounding, and access to compounded medications. H.R. 2871, Preserving Patient Access to Compounded Medications Act of 2017.
Client expense: — · Firm income: $10,000
Matched citations: H.R. 2871
Source: Senate LDA